ATE220687T1 - Die erzeugung einer immunantwort gegen erwünschte determinanten - Google Patents
Die erzeugung einer immunantwort gegen erwünschte determinantenInfo
- Publication number
- ATE220687T1 ATE220687T1 AT97902074T AT97902074T ATE220687T1 AT E220687 T1 ATE220687 T1 AT E220687T1 AT 97902074 T AT97902074 T AT 97902074T AT 97902074 T AT97902074 T AT 97902074T AT E220687 T1 ATE220687 T1 AT E220687T1
- Authority
- AT
- Austria
- Prior art keywords
- immune response
- generation
- response against
- against desired
- determinants
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/605—MHC molecules or ligands thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Compounds Of Unknown Constitution (AREA)
- Steroid Compounds (AREA)
- Control Of High-Frequency Heating Circuits (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1051096P | 1996-01-24 | 1996-01-24 | |
| PCT/US1997/001041 WO1997026784A1 (en) | 1996-01-24 | 1997-01-23 | Induction of immune response against desired determinants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE220687T1 true ATE220687T1 (de) | 2002-08-15 |
Family
ID=21746084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97902074T ATE220687T1 (de) | 1996-01-24 | 1997-01-23 | Die erzeugung einer immunantwort gegen erwünschte determinanten |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0876398B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4063879B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1214051A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE220687T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU1582797A (cg-RX-API-DMAC7.html) |
| BR (1) | BR9710404A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2242878C (cg-RX-API-DMAC7.html) |
| DE (1) | DE69714011T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0876398T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2177927T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT876398E (cg-RX-API-DMAC7.html) |
| WO (1) | WO1997026784A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6528061B1 (en) * | 1997-09-04 | 2003-03-04 | Pasteur Institut | Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions |
| EP1903056A3 (en) | 2002-12-10 | 2008-05-07 | Idm Pharma, Inc. | HLA-A1, -A2 -A3, -A24, -B7, and -B44 binding peptides comprising tumor associated antigen epitopes, and compositions thereof |
| CA2505870A1 (en) * | 2002-12-11 | 2004-06-24 | Soren Mouritsen | Targeting single epitopes |
| AU2004232971A1 (en) | 2003-04-18 | 2004-11-04 | Idm Pharma Inc. | HLA-A2 tumor associated antigen peptides and compositions |
| ES2310072B1 (es) | 2005-12-23 | 2009-11-16 | Proyecto De Biomedicina Cima, S.L. | Nuevos peptidos determinantes antigenicos t colaboradores (/dth). |
| WO2009025777A1 (en) * | 2007-08-17 | 2009-02-26 | University Of Maryland | Carbohydrate functionalized catanionic surfactant vesicles for drug delivery |
| JP5792630B2 (ja) * | 2009-01-28 | 2015-10-14 | エピミューン，インコーポレイティド | Ｐａｎ−ｄｒ結合ポリペプチドおよびその使用 |
| WO2012123269A1 (en) | 2011-03-11 | 2012-09-20 | Proyecto De Biomedicina Cima, S.L. | Immunogenic compositions and methods for their use |
| US10588952B2 (en) * | 2013-03-29 | 2020-03-17 | Sumitomo Dainippon Pharma Co., Ltd. | Conjugate vaccine using trimming function of ERAP1 |
| EP2982681B8 (en) | 2013-03-29 | 2018-11-07 | Sumitomo Dainippon Pharma Co., Ltd. | Wt1-antigen peptide conjugate vaccine |
| EP3028048B1 (en) | 2013-07-31 | 2018-09-26 | BioVentures, LLC | Compositions for treating and preventing cancer targeting tumor associated carbohydrate antigens |
| MX2016012124A (es) * | 2014-03-19 | 2017-04-06 | Mackay Medical Found The Presbyterian Church In Taiwan Mackay Memorial Hospital | Anticuerpos contra glicopeptidos inmunogenicos, composicion que los comprende y usos de estos. |
| JP7209963B2 (ja) | 2016-11-30 | 2023-01-23 | 住友ファーマ株式会社 | Ｗｔ１ヘルパーペプチド及びこれと癌抗原ペプチドコンジュゲート体との組合せ |
| CN107141355B (zh) * | 2017-05-31 | 2021-05-14 | 中国人民解放军第四军医大学 | 一种htnv抗原表位线性串联多肽及表位肽-复合物四聚体和应用 |
| CN109991422A (zh) * | 2017-12-29 | 2019-07-09 | 复旦大学 | 基于特异抗血清的棕榈酰化修饰蛋白质的检测方法 |
| EP4149531A1 (en) | 2020-05-11 | 2023-03-22 | Ose Immunotherapeutics | Vaccine against sars-cov virus |
| KR102261457B1 (ko) * | 2020-07-22 | 2021-06-09 | (주)쓰리에이치바이오 | 면역 치료제용 펩타이드 |
| KR20230042053A (ko) * | 2020-07-22 | 2023-03-27 | (주)쓰리에이치바이오 | 면역 치료제용 펩타이드 |
| WO2022268916A2 (en) | 2021-06-23 | 2022-12-29 | Ose Immunotherapeutics | Pan-coronavirus peptide vaccine |
| CN119256003A (zh) | 2022-04-14 | 2025-01-03 | 儿童医院 | 基于pfcsp的免疫原及其相关组合物和方法 |
| WO2025093541A1 (en) | 2023-10-31 | 2025-05-08 | Ose Immunotherapeutics | Combination of interleukin 7 and tumour associated antigen vaccine |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69435292D1 (de) * | 1993-03-05 | 2010-06-17 | Epimmune Inc | Verfahren zur herstellung von immunogenen hla-a2.1-bindenden peptiden |
| WO1995007707A1 (en) * | 1993-09-14 | 1995-03-23 | Cytel Corporation | Alteration of immune response using pan dr-binding peptides |
-
1997
- 1997-01-23 CA CA2242878A patent/CA2242878C/en not_active Expired - Lifetime
- 1997-01-23 BR BR9710404A patent/BR9710404A/pt not_active IP Right Cessation
- 1997-01-23 PT PT97902074T patent/PT876398E/pt unknown
- 1997-01-23 DE DE69714011T patent/DE69714011T2/de not_active Expired - Lifetime
- 1997-01-23 EP EP97902074A patent/EP0876398B1/en not_active Expired - Lifetime
- 1997-01-23 CN CN97193221A patent/CN1214051A/zh active Pending
- 1997-01-23 DK DK97902074T patent/DK0876398T3/da active
- 1997-01-23 JP JP52697997A patent/JP4063879B2/ja not_active Expired - Lifetime
- 1997-01-23 AU AU15827/97A patent/AU1582797A/en not_active Abandoned
- 1997-01-23 AT AT97902074T patent/ATE220687T1/de active
- 1997-01-23 ES ES97902074T patent/ES2177927T3/es not_active Expired - Lifetime
- 1997-01-23 WO PCT/US1997/001041 patent/WO1997026784A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| PT876398E (pt) | 2002-12-31 |
| BR9710404A (pt) | 1999-08-17 |
| WO1997026784A1 (en) | 1997-07-31 |
| DK0876398T3 (da) | 2002-08-12 |
| JP2000504328A (ja) | 2000-04-11 |
| CA2242878C (en) | 2010-06-22 |
| DE69714011T2 (de) | 2003-02-27 |
| AU1582797A (en) | 1997-08-20 |
| CN1214051A (zh) | 1999-04-14 |
| CA2242878A1 (en) | 1997-07-31 |
| EP0876398A1 (en) | 1998-11-11 |
| EP0876398B1 (en) | 2002-07-17 |
| ES2177927T3 (es) | 2002-12-16 |
| DE69714011D1 (de) | 2002-08-22 |
| JP4063879B2 (ja) | 2008-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE220687T1 (de) | Die erzeugung einer immunantwort gegen erwünschte determinanten | |
| CY1108074T1 (el) | Ανοσολογικες μεθοδοι για τη ρυθμιση της μυοστατινης σε σπονδυλωτα | |
| DE69929444D1 (de) | Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung | |
| EP2269632A3 (en) | Immunostimulatory compositions and methods of stimulating an immune response | |
| JO2305B1 (en) | Gels extracted from wood | |
| CY1112927T1 (el) | Αντισωματα κατα της ανθρωπινης il-12 | |
| DK0662005T3 (da) | Mikropartikelpræparater af biologisk nedbrydelige copolymerer | |
| AU4324896A (en) | Vaccine adjuvants | |
| ATE397005T1 (de) | Sialyl-lewisa und sialyl-lewisx epitope analoge | |
| IS5329A (is) | Flutningskerfi fyrir antígen þar sem monoglýseríðeða díglýseríð afleiður eru ónæmisglæðar | |
| DE69839696D1 (de) | Anellierte dihydropyrane | |
| ATE404667T1 (de) | Chromatin-regulatorgene | |
| UY24654A1 (es) | Composición de vacuna contra la malaria | |
| NO964238D0 (no) | Halofantrin-fri-base for behandling av malaria og blandinger | |
| DK0868491T3 (da) | Voks-frit møbelpolermiddel med siliconebestanddele | |
| GB9504940D0 (en) | Composition and method of preparing microemulsion blends | |
| NO20001421L (no) | T-cellevaksinasjon for behandling av multippel sklerose | |
| DK1146906T3 (da) | Mukosalt afgivelsessystem | |
| DK0786004T3 (da) | Kloning, ekspression og karakterisering af en hidtil ukendt form af phosphatidylinositol-3-kinase | |
| TR200001102T2 (tr) | İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları. | |
| CY1110718T1 (el) | Ανοσογονες λιποσωμικες συνθεσεις | |
| ES2192610T3 (es) | Aminouracilos substituidos. | |
| DK0787135T3 (da) | Vandopløslige derivater af epipodophyllotoxin, fremgangsmåde til fremstilling deraf og anvendelse som et lægemiddel til beh | |
| BG100248A (bg) | Инхибитори на скваленсинтетаза | |
| FR2715304B1 (fr) | Vaccin anti-allergique. |